The short version of Cardarine fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-04-18. Anything still debated is marked as such rather than presented as settled.
Cardarine has no approved therapeutic indication and is not marketed as a medicine. The World Anti-Doping Agency lists GW501516 as a prohibited substance at all times, covering both in-competition and out-of-competition periods. National laws vary: some countries treat it as an unapproved drug subject to import controls, while others have specific restrictions on sale for human consumption. It is often sold as a research chemical, a label that does not imply safety or legality. Enforcement actions have targeted online vendors and shipments.
Anti-doping laboratories identify GW501516 and related metabolites using liquid chromatography coupled with tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be analyzed. The method targets the parent compound and phase I and phase II metabolites, which extend the detection window. Because the substance is prohibited at all times, athletes can be tested outside competition. Detection limits and windows depend on the assay, sample type, and individual metabolism.
Cardarine is frequently described as a fat-burning or endurance-enhancing supplement, but these claims exceed the available evidence. The compound is not a hormone, steroid, or selective androgen receptor modulator. Research articles discuss it as a tool compound for studying PPARδ biology, while anti-doping literature focuses on its abuse and detection. Quality of unapproved products is uncertain, and independent analyses have found impurities or incorrect labeling. Open questions include whether human cancer risk resembles that seen in rodents and how often non-athletes use the substance.
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Prohibited in sport; not approved as medicine | Listed by WADA at all times. |
| Common synonyms | GW501516, GW-501516, endurobol | Cardarine is a colloquial name. |
| Typical analytical method | LC-MS/MS | Detects parent compound and metabolites. |
| Common test matrix | Urine | Blood and dried blood spots also possible. |
| Legal classification | Varies by country | Often treated as unapproved drug or research chemical. |
In laboratory settings, cardarine is studied as a tool compound for probing PPARδ biology. Published experiments often use cell cultures, rodent models, or isolated tissues. Some investigations focus on metabolic effects, while others assess potential risks such as carcinogenicity observed in long-term animal studies. Because human trials are sparse, most knowledge comes from preclinical work and adverse event reports. Scientific literature frequently notes the gap between animal findings and human outcomes. The compound is not a dietary supplement and is not intended for human consumption.
Cardarine is a common name for GW501516, a synthetic compound developed in the 1990s through research collaborations involving GlaxoSmithKline. It belongs to a class of molecules known as peroxisome proliferator-activated receptor delta agonists. Early studies explored its effects on lipid metabolism and energy expenditure in animal models. The compound was never approved as a human medicine, and clinical development was discontinued. In the years since, it has appeared in fitness and bodybuilding communities as a performance-enhancing substance. Regulatory agencies classify it as an unapproved drug.
PPARδ is a nuclear receptor that regulates gene expression related to fatty acid oxidation, glucose homeostasis, and mitochondrial function. GW501516 binds to this receptor with high affinity and activates downstream signaling in skeletal muscle and other tissues. Animal studies reported increased endurance and altered fuel preference, but human data remain limited and inconsistent. The precise relationship between receptor activation and observed physiological changes is still an area of active investigation. Researchers have also examined whether the compound affects inflammation or cell proliferation. No approved therapeutic indication exists for cardarine.
Literature on cardarine often separates receptor pharmacology from toxicology. Mechanistic papers describe PPARδ activation and gene expression changes, while safety assessments focus on carcinogenicity and species differences. Questions remain about whether rodent tumors arise through PPARδ-dependent or off-target mechanisms. Another open area is how human metabolism and exposure compare with those in animal studies. Analytical methods such as liquid chromatography–mass spectrometry are used to confirm identity in biological and product samples.
GW501516 acts as an agonist at the peroxisome proliferator-activated receptor delta, a nuclear receptor that regulates gene expression. Activation shifts transcription toward genes involved in fatty acid uptake, oxidation, and energy expenditure. The compound does not bind the androgen receptor and therefore differs from anabolic steroids and SARMs. In rodent models, this metabolic shift has been linked to increased running endurance and reduced fat accumulation. The exact downstream pathways in humans remain incompletely characterized.
Products sold as cardarine have been found to contain incorrect compounds, variable amounts, or no active ingredient at all. Independent testing is required to verify identity and purity. Common analytical approaches include high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance for structural confirmation. These methods can distinguish GW501516 from related PPAR agonists and from unrelated steroids. For regulators and researchers, such verification is central to interpreting both biological results and adverse event reports.
Cardarine is prohibited in competitive sport under the World Anti-Doping Agency code, where it is classified as a metabolic modulator. It is not approved as a prescription medicine in the United States, European Union, or other major markets. Regulatory action has focused on its presence in sports and in products marketed as research chemicals. Because it has no accepted medical indication, supply is often unregulated. This status creates legal and safety uncertainties for anyone who encounters the substance.
Anti-doping laboratories detect GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be used in some programs. Detection depends on factors such as dose, timing, metabolism, and the sensitivity of the assay. Published methods describe limits of detection in the low nanogram per milliliter range for related compounds. Exact detection windows are not fixed for all situations and remain an area of ongoing study.
=== Attention deficit hyperactivity disorder === In the United States, the treatment of attention deficit hyperactivity disorder (ADHD) is not an approved indication of bupropion, and it is not mentioned in the 2019 guideline on ADHD treatment from the American Academy of Pediatrics. Systematic reviews of bupropion for the treatment of ADHD in both adults and children note that bupropion may be effective for ADHD but warn that this conclusion has to be interpreted with caution, because clinical trials were of low quality due to small sizes and risk of bias. Similarly to atomoxetine, bupropion has a delayed onset of action for ADHD, and several weeks of treatment are required for therapeutic effects. This is in contrast to stimulants, such as amphetamine and methylphenidate, which have an immediate onset of effect in the condition.
Recent Govt initiatives include digitalization of PACS,introduction of model by-laws for formation of new primary cooperatives,preference of cooperatives for common service center and jan aushadhi stores.Ministry of Cooperation has launched white revolution 2.0 for resilent milk production and procurement by cooperatives.
== Genetics == Six genes have been found to be associated with the condition. These genes include BANP-ZNF469, COL4A4, FOXO1, FNDC3B, IMMP2L and RXRA-COL5A1. Others likely also exist. Patients with a parent, sibling, or child who has keratoconus have 15 to 67 times higher risk in developing corneal ectasia compared to patients with no affected relatives.
== Regeneration == In zebrafish, which regenerate beta cells throughout life, single-cell RNA sequencing of the adult pancreas has been used to define the cell populations that contribute to beta-cell regeneration. These analyses identified a population of krt4-expressing ductal cells that act as ductal progenitors of endocrine cells and can give rise to insulin-producing cells following beta-cell ablation. Single-cell atlases of de novo regeneration have further shown that bihormonal hybrid cells co-expressing insulin (ins) and somatostatin (sst1.1) form after beta-cell loss and serve as a major source of new insulin-expressing cells during the recovery of glucose homeostasis. Because endocrine differentiation in zebrafish is largely conserved with that of mammals, these models are used to study mechanisms that might be applied to stimulate beta-cell regeneration in diabetes.
Sources: en.wikipedia.org
Coldspring Pilgrim's Pride Cold Spring Brewing Company. Founded in 1874 by German immigrant Michael Sargl, CSBC produces, packages, and distributes soft drinks, beer, malt beverages, energy drinks, and other beverages. In 2012, the Third Street Brewhouse was started and became CSBC's craft beer division. Brynwood Partners, a Connecticut-based private equity firm, bought the company from the Lenore family in August 2017. At the time, the company had roughly 350 employees and annual sales of more than $60 million. Rocori School District Assumption Community Cold Spring Bakery. Started in 1946 by Melvin and Floss Schurman, and originally known as the Home Bakery, the bakery is on Main Street. It distributes its goods across Central Minnesota and is still owned and managed by the Schurman family.
In the pancreas, osteocalcin acts on beta cells, causing beta cells in the pancreas to release more insulin. In fat cells, osteocalcin triggers the release of the adiponectin hormone, which increases insulin sensitivity. In muscle, osteocalcin acts on myocytes to promote energy availability and utilization and, in this manner, favors exercise capacity. In the testes, osteocalcin acts on Leydig cells, stimulating testosterone biosynthesis and affecting male fertility. In the brain, osteocalcin plays an important role in development and functioning, including spatial learning and memory. An acute stress response (ASR), colloquially known as the fight-or-flight response, stimulates osteocalcin release from bone within minutes in mice, rats, and humans. Injections of high levels of osteocalcin alone can trigger an ASR in the presence of adrenal insufficiency.
== External links == Media related to Eflornithine at Wikimedia Commons Clinical trial number NCT02395666 for "Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission" at ClinicalTrials.gov Clinical trial number NCT02679144 for "Neuroblastoma Maintenance Therapy Trial (NMTT)" at ClinicalTrials.gov
Kevin Darnell Hart (born July 6, 1979) is an American comedian and actor. After winning several stand-up comedy competitions, Hart had his first breakthrough when Judd Apatow cast him in a recurring role on the TV series Undeclared (2001). Hart's comedic reputation continued to grow with the release of his first stand-up album I'm a Grown Little Man (2009). He has since released four more comedy albums: Seriously Funny (2010), Laugh at My Pain (2011), Let Me Explain (2013), and What Now? (2016). As an actor, Hart has had roles in films such as Paper Soldiers (2002), Scary Movie 3 (2003), Soul Plane (2004), In the Mix (2005), Little Fockers (2010), Think Like a Man (2012), Grudge Match (2013), Ride Along (2014), About Last Night (2014), Get Hard (2015), Central Intelligence (2016), The Secret Life of Pets film franchise (2016–2019), Ride Along 2 (2016), Captain Underpants: The First Epic Movie (2017), the Jumanji film franchise (2017–present), and Night School (2018). He also created and starred as a fictionalized version of himself in Real Husbands of Hollywood (2013–2016). In 2017, he launched the Laugh Out Loud Network, a subscription video streaming service in partnership with Lionsgate. Hart has received numerous accolades including the Mark Twain Prize for American Humor in 2024, and nominations for two Grammy Awards and four Primetime Emmy Awards. In 2015, Time magazine named him on its annual list of the 100 most influential people in the world.
== Etymology == The word pepper derives from Old English pipor, Latin piper, and Greek πέπερι. The Greek likely derives from Sanskrit. In the 16th century, people began using pepper to also mean the New World chilli pepper (genus Capsicum), which is not closely related.
Sources: en.wikipedia.org
Legal status varies by country. It is not approved as a medicine, and it is prohibited in sport. Some jurisdictions restrict import, sale, or possession.
Laboratories use liquid chromatography-tandem mass spectrometry to detect GW501516 and its metabolites. Urine is commonly tested, and testing can occur in and out of competition.
No, cardarine is not a SARM. It is a PPARδ agonist, which acts on a different receptor. The two classes are often confused in online discussions.
No. Cardarine has not received approval for human therapeutic use in major jurisdictions. It remains an investigational compound.